About Catasys (NASDAQ:CATS)
Catasys, Inc. provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak solution combines medical and psychosocial treatments with elements of traditional disease management, case management, and ongoing member support to help organizations treat and manage populations struggling with substance dependence, depression, and anxiety to improve their health and thereby decrease their health care costs. Catasys, Inc.s OnTrak solution includes various components, such as identification of impactable members, member engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California.
Industry, Sector and Symbol
Industry Specialized Health Services
SymbolNASDAQ:CATSPrevious Symbol: OTCMKTS:CATS
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$7.07 million
Price / Sales8.92
Price / CashN/A
Book Value$0.21 per share
Price / Book18.90
Return on EquityN/A
Return on Assets-210.45%
Frequently Asked Questions for Catasys (NASDAQ:CATS)
What is Catasys' stock symbol?
Catasys trades on the NASDAQ under the ticker symbol "CATS."
How were Catasys' earnings last quarter?
Catasys Inc. (NASDAQ:CATS) announced its quarterly earnings results on Monday, May, 16th. The company reported ($0.05) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.05). View Catasys' Earnings History.
When will Catasys make its next earnings announcement?
Where is Catasys' stock going? Where will Catasys' stock price be in 2017?
2 equities research analysts have issued twelve-month price objectives for Catasys' stock. Their predictions range from $8.00 to $8.00. On average, they expect Catasys' share price to reach $8.00 in the next year. View Analyst Ratings for Catasys.
Who are some of Catasys' key competitors?
Some companies that are related to Catasys include Cumberland Pharmaceuticals (CPIX), Oramed Pharmaceuticals (ORMP), Trillium Therapeutics (TRIL), CTI BioPharma Corp. (CTIC), ArQule (ARQL), Adocia (ADOCY), Ophthotech Corporation (OPHT), Conatus Pharmaceuticals (CNAT), Ocular Therapeutix (OCUL), Aldeyra Therapeutics (ALDX), aTyr Pharma (LIFE), Eiger BioPharmaceuticals (EIGR), Axsome Therapeutics (AXSM), Opexa Therapeutics (ACER), Aralez Pharmaceuticals (ARLZ), Vermillion (VRML), Redhill Biopharma (RDHL) and KalVista Pharmaceuticals (KALV).
When did Catasys' lock-up period expire?
Catasys' lock-up period expired on Monday, October 23rd. Catasys had issued 3,125,000 shares in its IPO on April 26th. The total size of the offering was $15,000,000 based on an initial share price of $4.80. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.
Who sold Catasys stock? Who is selling Catasys stock?
How do I buy Catasys stock?
Shares of Catasys can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Catasys' stock price today?
One share of Catasys stock can currently be purchased for approximately $3.97.
How big of a company is Catasys?
Catasys has a market capitalization of $63.08 million and generates $7.07 million in revenue each year. The company earns $-17,930,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis. Catasys employs 88 workers across the globe.
How can I contact Catasys?
Catasys' mailing address is 11601 WILSHIRE BLVD. SUITE 1100, LOS ANGELES CA, 90025. The company can be reached via phone at 310-444-4300 or via email at [email protected]
MarketBeat Community Rating for Catasys (CATS)MarketBeat's community ratings are surveys of what our community members think about Catasys and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Catasys (NASDAQ:CATS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||$8.00 (101.51% upside)|
Consensus Price Target History for Catasys (NASDAQ:CATS)
Analysts' Ratings History for Catasys (NASDAQ:CATS)
(Data available from 11/24/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/18/2017||Taglich Brothers||Initiated Coverage||Speculative Buy||$8.00||N/A|
|10/18/2017||Telsey Advisory Group||Initiated Coverage||Buy||N/A|
Earnings History and Estimates Chart for Catasys (NASDAQ:CATS)
Earnings History by Quarter for Catasys (NASDAQ CATS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/7/2018|| || || || || || || || |
|8/15/2017||Q2 2017||($0.20)||($0.23)||$1.67 million||View||N/A|
Earnings Estimates for Catasys (NASDAQ:CATS)
2017 EPS Consensus Estimate: ($0.29)
2018 EPS Consensus Estimate: ($0.18)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Catasys (NASDAQ:CATS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Catasys (NASDAQ CATS)
Insider Ownership Percentage: 92.20%
Institutional Ownership Percentage: 6.03%
Insider Trades by Quarter for Catasys (NASDAQ CATS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/28/2017||Terren S Peizer||CEO||Buy||181,154||$4.80||$869,539.20|| |
|10/16/2015||Steve Gorlin||Director||Buy||300,000||$0.30||$90,000.00|| |
|10/16/2015||Terren S Peizer||CEO||Buy||5,410,000||$0.30||$1,623,000.00|| |
|9/17/2015||Terren S Peizer||CEO||Buy||1,543,334||$0.30||$463,000.20|| |
|12/23/2014||Terren S Peizer||CEO||Buy||70,000||$2.00||$140,000.00|| |
|5/27/2014||Terren S Peizer||CEO||Buy||2,077,587||$0.58||$1,205,000.46|| |
|1/31/2014||Terren S Peizer||CEO||Buy||1,585,345||$0.58||$919,500.10|| |
|10/15/2013||Terren S Peizer||CEO||Buy||3,448,276||$0.58||$2,000,000.08|| |
|4/10/2013||Terren S Peizer||CEO||Buy||17,300,000||$0.07||$1,211,000.00|| |
|12/4/2012||Terren S Peizer||CEO||Buy||35,714,286||$0.07||$2,500,000.02|| |
|9/13/2012||Terren S Peizer||CEO||Buy||9,810,000||$0.10||$981,000.00|| |
Latest Headlines for Catasys (NASDAQ CATS)
Catasys (NASDAQ CATS) Chart for Friday, November, 24, 2017